168 related articles for article (PubMed ID: 31574855)
1. Chronic hepatitis C virus infection: Relationships between inflammatory marker levels and compensated liver cirrhosis.
Li X; Wang L; Gao P
Medicine (Baltimore); 2019 Sep; 98(39):e17300. PubMed ID: 31574855
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A; Abdou A; El-Neanaey WA; Diab I
Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
7. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis.
Loaeza-del-Castillo A; Paz-Pineda F; Oviedo-Cárdenas E; Sánchez-Avila F; Vargas-Vorácková F
Ann Hepatol; 2008; 7(4):350-7. PubMed ID: 19034235
[TBL] [Abstract][Full Text] [Related]
8. New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis.
Wang HW; Peng CY; Lai HC; Su WP; Lin CH; Chuang PH; Chen SH; Chen CH; Hsu WF; Huang GT
Sci Rep; 2017 Jun; 7(1):3259. PubMed ID: 28607450
[TBL] [Abstract][Full Text] [Related]
9. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study.
Köksal İ; Yılmaz G; Parlak M; Demirdal T; Kınıklı S; Candan M; Kaya A; Akhan S; Aydoğdu Ö; Turgut H; Gürbüz Y; Dağlı Ö; Gökal AA; Güner R; Kuruüzüm Z; Tarakçı H; Beslen N; Erdoğan S; Özdener F; Study Group TCHC
Turk J Gastroenterol; 2018 Jul; 29(4):464-472. PubMed ID: 30249562
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
[TBL] [Abstract][Full Text] [Related]
12. A simple approach to noninvasively identifying significant fibrosis in chronic hepatitis C patients in clinical practice.
Giannini EG; Zaman A; Ceppa P; Mastracci L; Risso D; Testa R
J Clin Gastroenterol; 2006 Jul; 40(6):521-7. PubMed ID: 16825935
[TBL] [Abstract][Full Text] [Related]
13. Aspartate aminotransferase-to-platelet ratio index for fibrosis and cirrhosis prediction in chronic hepatitis C patients.
Silva RG; Fakhouri R; Nascimento TV; Santos IM; Barbosa LM
Braz J Infect Dis; 2008 Feb; 12(1):15-9. PubMed ID: 18553008
[TBL] [Abstract][Full Text] [Related]
14. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
Eminler AT; Ayyildiz T; Irak K; Kiyici M; Gurel S; Dolar E; Gulten M; Nak SG
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
[TBL] [Abstract][Full Text] [Related]
15. Liver cirrhosis: a risk factor for gallstone disease in chronic hepatitis C patients in China.
Li X; Wang Z; Wang L; Pan M; Gao P
Medicine (Baltimore); 2017 Jun; 96(26):e7427. PubMed ID: 28658178
[TBL] [Abstract][Full Text] [Related]
16. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients.
Li X; Xu H; Gao P
Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive markers for staging fibrosis in chronic delta hepatitis.
Takyar V; Surana P; Kleiner DE; Wilkins K; Hoofnagle JH; Liang TJ; Heller T; Koh C
Aliment Pharmacol Ther; 2017 Jan; 45(1):127-138. PubMed ID: 27813124
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
[TBL] [Abstract][Full Text] [Related]
19. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
[TBL] [Abstract][Full Text] [Related]
20. Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients.
Arabul M; Aslan F; Alper E; Akpinar Z; Çelık M; Kandemır A; Vatansever S; Ünsal B
Turk J Gastroenterol; 2012; 23(5):538-45. PubMed ID: 23161299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
